Forskning ved Københavns Universitet - Københavns Universitet

Forside

Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging : a histogram analysis approach. / Falk, Anna; Fahlström, Markus; Rostrup, Egill; Berntsson, Shala; Zetterling, Maria; Morell, Arvid; Larsson, Henrik B W; Smits, Anja; Larsson, Elna-Marie.

I: Neuroradiology, Bind 56, Nr. 12, 12.2014, s. 1031-1038.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Falk, A, Fahlström, M, Rostrup, E, Berntsson, S, Zetterling, M, Morell, A, Larsson, HBW, Smits, A & Larsson, E-M 2014, 'Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach', Neuroradiology, bind 56, nr. 12, s. 1031-1038. https://doi.org/10.1007/s00234-014-1426-z

APA

Falk, A., Fahlström, M., Rostrup, E., Berntsson, S., Zetterling, M., Morell, A., Larsson, H. B. W., Smits, A., & Larsson, E-M. (2014). Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology, 56(12), 1031-1038. https://doi.org/10.1007/s00234-014-1426-z

Vancouver

Falk A, Fahlström M, Rostrup E, Berntsson S, Zetterling M, Morell A o.a. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology. 2014 dec;56(12):1031-1038. https://doi.org/10.1007/s00234-014-1426-z

Author

Falk, Anna ; Fahlström, Markus ; Rostrup, Egill ; Berntsson, Shala ; Zetterling, Maria ; Morell, Arvid ; Larsson, Henrik B W ; Smits, Anja ; Larsson, Elna-Marie. / Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging : a histogram analysis approach. I: Neuroradiology. 2014 ; Bind 56, Nr. 12. s. 1031-1038.

Bibtex

@article{3670d9c6645c46b2aee06b8a9f60de1c,
title = "Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach",
abstract = "INTRODUCTION: Perfusion magnetic resonance imaging (MRI) can be used in the pre-operative assessment of brain tumours. The aim of this prospective study was to identify the perfusion parameters from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) perfusion imaging that could best discriminate between grade II and III gliomas.METHODS: MRI (3 T) including morphological ((T2 fluid attenuated inversion recovery (FLAIR) and T1-weighted (T1W)+Gd)) and perfusion (DCE and DSC) sequences was performed in 39 patients with newly diagnosed suspected low-grade glioma after written informed consent in this review board-approved study. Regions of interests (ROIs) in tumour area were delineated on FLAIR images co-registered to DCE and DSC, respectively, in 25 patients with histopathological grade II (n = 18) and III (n = 7) gliomas. Statistical analysis of differences between grade II and grade III gliomas in histogram perfusion parameters was performed, and the areas under the curves (AUC) from the ROC analyses were evaluated.RESULTS: In DCE, the skewness of transfer constant (k(trans)) was found superior for differentiating grade II from grade III in all gliomas (AUC 0.76). In DSC, the standard deviation of relative cerebral blood flow (rCBF) was found superior for differentiating grade II from grade III gliomas (AUC 0.80).CONCLUSIONS: Histogram parameters from k(trans) (DCE) and rCBF (DSC) could most efficiently discriminate between grade II and grade III gliomas.",
author = "Anna Falk and Markus Fahlstr{\"o}m and Egill Rostrup and Shala Berntsson and Maria Zetterling and Arvid Morell and Larsson, {Henrik B W} and Anja Smits and Elna-Marie Larsson",
year = "2014",
month = dec,
doi = "10.1007/s00234-014-1426-z",
language = "English",
volume = "56",
pages = "1031--1038",
journal = "Neuroradiology",
issn = "0028-3940",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging

T2 - a histogram analysis approach

AU - Falk, Anna

AU - Fahlström, Markus

AU - Rostrup, Egill

AU - Berntsson, Shala

AU - Zetterling, Maria

AU - Morell, Arvid

AU - Larsson, Henrik B W

AU - Smits, Anja

AU - Larsson, Elna-Marie

PY - 2014/12

Y1 - 2014/12

N2 - INTRODUCTION: Perfusion magnetic resonance imaging (MRI) can be used in the pre-operative assessment of brain tumours. The aim of this prospective study was to identify the perfusion parameters from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) perfusion imaging that could best discriminate between grade II and III gliomas.METHODS: MRI (3 T) including morphological ((T2 fluid attenuated inversion recovery (FLAIR) and T1-weighted (T1W)+Gd)) and perfusion (DCE and DSC) sequences was performed in 39 patients with newly diagnosed suspected low-grade glioma after written informed consent in this review board-approved study. Regions of interests (ROIs) in tumour area were delineated on FLAIR images co-registered to DCE and DSC, respectively, in 25 patients with histopathological grade II (n = 18) and III (n = 7) gliomas. Statistical analysis of differences between grade II and grade III gliomas in histogram perfusion parameters was performed, and the areas under the curves (AUC) from the ROC analyses were evaluated.RESULTS: In DCE, the skewness of transfer constant (k(trans)) was found superior for differentiating grade II from grade III in all gliomas (AUC 0.76). In DSC, the standard deviation of relative cerebral blood flow (rCBF) was found superior for differentiating grade II from grade III gliomas (AUC 0.80).CONCLUSIONS: Histogram parameters from k(trans) (DCE) and rCBF (DSC) could most efficiently discriminate between grade II and grade III gliomas.

AB - INTRODUCTION: Perfusion magnetic resonance imaging (MRI) can be used in the pre-operative assessment of brain tumours. The aim of this prospective study was to identify the perfusion parameters from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) perfusion imaging that could best discriminate between grade II and III gliomas.METHODS: MRI (3 T) including morphological ((T2 fluid attenuated inversion recovery (FLAIR) and T1-weighted (T1W)+Gd)) and perfusion (DCE and DSC) sequences was performed in 39 patients with newly diagnosed suspected low-grade glioma after written informed consent in this review board-approved study. Regions of interests (ROIs) in tumour area were delineated on FLAIR images co-registered to DCE and DSC, respectively, in 25 patients with histopathological grade II (n = 18) and III (n = 7) gliomas. Statistical analysis of differences between grade II and grade III gliomas in histogram perfusion parameters was performed, and the areas under the curves (AUC) from the ROC analyses were evaluated.RESULTS: In DCE, the skewness of transfer constant (k(trans)) was found superior for differentiating grade II from grade III in all gliomas (AUC 0.76). In DSC, the standard deviation of relative cerebral blood flow (rCBF) was found superior for differentiating grade II from grade III gliomas (AUC 0.80).CONCLUSIONS: Histogram parameters from k(trans) (DCE) and rCBF (DSC) could most efficiently discriminate between grade II and grade III gliomas.

U2 - 10.1007/s00234-014-1426-z

DO - 10.1007/s00234-014-1426-z

M3 - Journal article

C2 - 25204450

VL - 56

SP - 1031

EP - 1038

JO - Neuroradiology

JF - Neuroradiology

SN - 0028-3940

IS - 12

ER -

ID: 137743437